Article Sidebar

pdf
Date Published: 15/05/2024
Abstract Views: 168
Views pdf: 93
DOI: https://doi.org/10.51298/vmj.v538i3.9563
Issue
Vol. 538 No. 3 (2024)
Section
Các bài báo
How to Cite
Phạm, T. A., Đặng, H. Q., & Trương, M. C. (2024). SHORT-TERM OUTCOMES OF ANATOMICAL LEFT HEPATECTOMY FOR INTRAHEPATIC CHOLANGIOCARCINOMA AT K HOSPITAL. Vietnam Medical Journal, 538(3). https://doi.org/10.51298/vmj.v538i3.9563

SHORT-TERM OUTCOMES OF ANATOMICAL LEFT HEPATECTOMY FOR INTRAHEPATIC CHOLANGIOCARCINOMA AT K HOSPITAL

Thế Anh Phạm, Hoàng Quốc Đặng, Mạnh Cường Trương

Main Article Content

Abstract

Objective: To evaluate the short-term outcomes of anatomical left hepatectomy for intrahepatic cholangiocarcinoma. Subject and method: This was a retrospective descriptive study of the cases who underwent anatomical left hepatetomy for intrahepatic cholangiocarcinoma at the Department of Hepatobiliary and Pancreatic Surgery in National Cancer Hospital from January 2021 to December 2023. Result: Elective surgery was performed for 19 patients. The average age was 56,6 ± 11,5 years; sex ratio was 0,58 male per 1 female; hepatitis B and hepatitis C related: 26,3%. CA 19-9 and CEA levels were elevated in 42,1% and 10,5% of cases, respectively. Most patients had a solitary tumor (89,5%) with a size larger than 5cm (21,1%) in a CT scan. All patients underwent local lymphadenectomy, including lymph nodes at the hepatoduodenal ligament along the common hepatic artery and retro-pancreatic space. The mean operation time was 158 ± 54,4 min. Postoperative pathology: IIIB TNM staging (47.4%), satellite nodules (21%), vascular invasion (0%), and lymph node metastases (47,4%). No patients had postoperative complications. There was no perioperative mortality. The average length of hospital stay was 16,7±14,3 days. Conclusion: Left hepatectomy for intrahepatic cholangiocarcinoma is a feasible, safe and effective method

Article Details

Keywords

: left hepatectomy, intrahepatic cholangiocarcinoma.

References

1. El-Diwany R, Pawlik T M, Ejaz A J S O C (2019), "Intrahepatic cholangiocarcinoma", 28 (4), pp. 587-599.
2. Dat T Q (2010), "Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và kết quả phẫu thuật cắt gan do ung thư đường mật trong gan", Luận văn bác sĩ nội trú Đại học Y Hà Nội.
3. Addeo P, Jedidi I, Locicero A, et al (2019), "Prognostic impact of tumor multinodularity in intrahepatic cholangiocarcinoma", 23, pp. 1801-1809.
4. Belghiti J, Noun R, Malafosse R, et al (1999), "Continuous versus intermittent portal triad clamping for liver resection: a controlled study", Annals of surgery, 229 (3), pp. 369.
5. Moris D, Palta M, Kim C, et al (2023), "Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians", 73 (2), pp. 198-222.
6. Huang J L, Biehl T R, Lee F T, et al (2004), "Outcomes after resection of cholangiocellular carcinoma", The American journal of surgery, 187 (5), pp. 612-617.
7. Sakamoto Y, Kokudo N, Matsuyama Y, et al (2016), "Proposal of a new staging system for intrahepatic cholangiocarcinoma: analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan", Cancer, 122 (1), pp. 61-70.
8. RuiYang W, ZhiMing Y, Jiao F, et al (2021), "Evaluation and recommendation of the 8th edition of American joint committee on cancer (AJCC) staging system for intrahepatic cholangiocarcinoma (ICC) in 820 patients from the surveillance, epidemiology, and end results (SEER) database", 25, pp. 145-154.
9. Ngô Đắc Sáng (2018), "Nghiên cứu các biến chứng sau phẫu thuật cắt gan do ung thư theo phương pháp Tôn Thất Tùng". Luận án Tiến sĩ, Học viện Quân Y.